Weight Loss Drug Wegovy Can Protect Against Heart Attacks
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It's the first weight-loss drug to carry an indication for heart benefits. The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.When the results of the study were first released at the American Heart Association meeting last November, the findings were greeted with a round of applause from the heart experts in attendance. Obesity is a major ...










